ArticleGenes & diseases2026

A parallel-risk framework accurately predicts hematopoietic stem cell transplantation outcomes and identifies benefiting patients in pediatric AML.

Yance Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.